Cargando…

Mutant p53 stimulates cell invasion through an interaction with Rad21 in human ovarian cancer cells

Missense mutations of TP53 are extremely common, and mutant p53 accumulation and gain-of-function play crucial roles in human ovarian cancer. Here, we investigated the role of mutant p53 in cell migration and invasion as well as its underlying molecular mechanisms in human ovarian cancer cells. Over...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Ji-Hye, Kim, Tae Jin, Lee, Jae Ho, Choi, Jung-Hye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567302/ https://www.ncbi.nlm.nih.gov/pubmed/28831167 http://dx.doi.org/10.1038/s41598-017-08880-4

Ejemplares similares

Author Correction: Mutant p53 stimulates cell invasion through an interaction with Rad21 in human ovarian cancer cells
por: Ahn, Ji-Hye, et al.
Publicado: (2018)

Mutant p53 promotes ovarian cancer cell adhesion to mesothelial cells via integrin β4 and Akt signals
por: Lee, Jong-Gyu, et al.
Publicado: (2015)

Mutant p53 in cell-cell interactions
por: Pilley, Steven, et al.
Publicado: (2021)

Mutant TP53 interacts with BCAR1 to contribute to cancer cell invasion
por: Guo, Alvin Kunyao, et al.
Publicado: (2020)

CC Chemokine Ligand 7 Derived from Cancer-Stimulated Macrophages Promotes Ovarian Cancer Cell Invasion
por: Jeong, Miran, et al.
Publicado: (2021)

Citromycin Isolated from the Antarctic Marine-Derived Fungi, Sporothrix sp., Inhibits Ovarian Cancer Cell Invasion via Suppression of ERK Signaling
por: Choi, He Yun, et al.
Publicado: (2022)

Deoxyschizandrin, Isolated from Schisandra Berries, Induces Cell Cycle Arrest in Ovarian Cancer Cells and Inhibits the Protumoural Activation of Tumour-Associated Macrophages
por: Lee, Kijun, et al.
Publicado: (2018)

p53 and its mutants in tumor cell migration and invasion
por: Muller, Patricia A. J., et al.
Publicado: (2011)

Protein phosphatase 2A interacts with Verthandi/Rad21 to regulate mitosis and organ development in Drosophila
por: Kim, Lee-Hyang, et al.
Publicado: (2019)

Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53
por: Alaee, Mahsa, et al.
Publicado: (2016)

P53 Gain-of-Function Mutants and Steroids in Ovarian Cancer Cell Metastasis
por: Candelaria, Nicholes, et al.
Publicado: (2021)

Rad9 modulates the P21(WAF1 )pathway by direct association with p53
por: Ishikawa, Kazuhiro, et al.
Publicado: (2007)

Analysis of the Tolerance to DNA Alkylating Damage in MEC1 and RAD53 Checkpoint Mutants of Saccharomyces cerevisiae
por: Gallego-Sánchez, Alfonso, et al.
Publicado: (2013)

Enhanced Efficacy of Combined Therapy with Checkpoint Kinase 1 Inhibitor and Rucaparib via Regulation of Rad51 Expression in BRCA Wild-Type Epithelial Ovarian Cancer Cells
por: Cho, Hye-yon, et al.
Publicado: (2021)

RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer
por: Deng, Peng, et al.
Publicado: (2022)

An FHA domain–mediated protein interaction network of Rad53 reveals its role in polarized cell growth
por: Smolka, Marcus B., et al.
Publicado: (2006)

Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion
por: Muller, P A J, et al.
Publicado: (2013)

Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability
por: Galanos, Panagiotis, et al.
Publicado: (2018)

Characterization of the Interaction between the Cohesin Subunits Rad21 and SA1/2
por: Zhang, Nenggang, et al.
Publicado: (2013)

CCDC106 promotes the proliferation and invasion of ovarian cancer cells by suppressing p21 transcription through a p53-independent pathway
por: Zhao, Na, et al.
Publicado: (2022)

Rad54 mutant stays rooted to the spot
por: Short, Ben
Publicado: (2011)

The human checkpoint sensor Rad9–Rad1–Hus1 interacts with and stimulates NEIL1 glycosylase
por: Guan, Xin, et al.
Publicado: (2007)

Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines
por: Davidson, Brittany Anne, et al.
Publicado: (2014)

LINC01605 Is a Novel Target of Mutant p53 in Breast and Ovarian Cancer Cell Lines
por: Coan, Michela, et al.
Publicado: (2023)

RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas
por: Deb, S, et al.
Publicado: (2014)

Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma
por: Lee, Hye-Jin, et al.
Publicado: (2015)

Samul-Tang Regulates Cell Cycle and Migration of Vascular Smooth Muscle Cells against TNF-α Stimulation
por: Choi, Eun Sik, et al.
Publicado: (2018)

Correction: Characterization of the Interaction between the Cohesin Subunits Rad21 and SA1/2
por: Zhang, Nenggang, et al.
Publicado: (2013)

DSS1 interacts with and stimulates RAD52 to promote the repair of DSBs
por: Stefanovie, Barbora, et al.
Publicado: (2020)

Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53
por: Lu, Phong, et al.
Publicado: (2019)

Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival()
por: Mullany, Lisa K., et al.
Publicado: (2015)

Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51
por: Wang, Bingliang, et al.
Publicado: (2015)

PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction
por: Ray, Upasana, et al.
Publicado: (2023)

Prevalent and dynamic binding of the cell cycle checkpoint kinase Rad53 to gene promoters
por: Sheu, Yi-Jun, et al.
Publicado: (2022)

Rad53 keeps watch over mitochondrial DNA
por: Short, Ben
Publicado: (2012)

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
por: Sonego, Maura, et al.
Publicado: (2014)

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
por: Sonego, Maura, et al.
Publicado: (2013)

Author Correction: Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability
por: Galanos, Panagiotis, et al.
Publicado: (2022)

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
por: Hofstetter, G, et al.
Publicado: (2011)

The human checkpoint sensor Rad9–Rad1–Hus1 interacts with and stimulates DNA repair enzyme TDG glycosylase
por: Guan, Xin, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_afipoosbb269sb6qccqovucmdk